Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

AJPH First Look, published online ahead of print Jan 15, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2008.136937v1
99/3/402    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, D.
Right arrow Articles by Khoshnood, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, D.
Right arrow Articles by Khoshnood, K.
Related Collections
Right arrow Health Policy
Right arrow Access to Care
Right arrow Drugs
March 2009, Vol 99, No. 3 | American Journal of Public Health 402-407
© 2009 American Public Health Association
DOI: 10.2105/AJPH.2008.136937

HEALTH POLICY AND ETHICS

Expanded Access to Naloxone: Options for Critical Response to the Epidemic of Opioid Overdose Mortality

Daniel Kim, MPH, Kevin S. Irwin, MA and Kaveh Khoshnood, PhD

Daniel Kim is with the American Medical Association, Chicago, IL. Kevin S. Irwin is with the Community Health Program, Tufts University, Boston, MA. Kaveh Khoshnood is with the Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT.

Correspondence: Requests for reprints should be sent to Kaveh Khoshnood, PhD, Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College Street #405, New Haven, CT 06520 (e-mail: kaveh.khoshnood{at}yale.edu).

The United States is in the midst of a prolonged and growing epidemic of accidental and preventable deaths associated with overdoses of licit and illicit opioids. For more than 3 decades, naloxone has been used by emergency medical personnel to pharmacologically reverse overdoses. The peers or family members of overdose victims, however, are most often the actual first responders and are best positioned to intervene within an hour of the onset of overdose symptoms.

Data from recent pilot programs demonstrate that lay persons are consistently successful in safely administering naloxone and reversing opioid overdose. Current evidence supports the extensive scaleup of access to naloxone. We present advantages and limitations associated with a range of possible policy and program responses.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Public Health Association